patent/BR-PI0410563-B8

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0410563-B8

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_436b489653124a7c40658a96293b471c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4a95c7328e9c63a07ce2de92c34d8f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eb6dbca25e5f9459a6c5f592728c787
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate	2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9211ace7d095612b3751bf0dc85f18f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee4d5a8fb477474c937d9573f547b3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617f2b761ec4c025694b48c8046ef289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5c115492521e627b4da08df43e037f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98f111257d96c8796fc376568cf45d73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30193bdce63b86a721631a18e7251f8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ec3e0e74ef3b06db0fe9223c8f6c08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_febc58dd9f33df3c2a25421891f18abe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1b09985b1f48930e43f34057f6819e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_034646b1efac49f50c9c670f51d59bf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee8c22a542ae07d0dd54e298014da64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a057b2b446d90f3aeaf2dc5f5bb85640
publicationDate	2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-PI0410563-B8
titleOfInvention	pyrazol-quinazoline compounds, their preparation processes and pharmaceutical compositions
abstract	pyrazol-quinazoline derivatives, process for their preparation and their use as kinase inhibitors. the present invention relates to the pyrazol-quinazoline derivatives of formula (ia) or (ib) as defined in the report, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising the same are described, the compounds of the invention may be usable, in therapy, in the treatment of diseases associated with an unregulated protein kinase activity, such as cancer.
priorityDate	2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157207291 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447665469

Total number of triples: 60.